Long-term Safety and Efficacy Study of Fentanyl Sublingual Spray for the Treatment of Breakthrough Cancer Pain
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to assess the 90-day safety of fentanyl sublingual spray for
the treatment of breakthrough cancer pain in subjects on around-the-clock opioids for their
persistent cancer pain.